Cholesterol-lowering and vascular reactivity in relation to coronary heart disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 3, 1999, Pages 133-142

  De Divitiis, M ^a   Rubba, P ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cholesterol lowering; Coronary heart disease; Endothelium; Vascular reactivity

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

CORONARY ARTERY DISEASE; DRUG EFFECT; HUMAN; HYPERCHOLESTEROLEMIA; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; MUSCLE, SMOOTH, VASCULAR; PROGNOSIS;

EID: 0033144119     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Shepherd J, Cobbe SM, Ford I, Isle CG, Lorimer AR, Mc Farlane PW, McKillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
2. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of Cholesterol-lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
3. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwal E (1996) The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009
4. Kreisberg RA (1996) Cholesterol-lowering and coronary atherosclerosis: good news and bad news. Am J Med 101: 455-458
5. Lo Scalzo J (1990) Regression of coronary atherosclerosis. N Engl J Med 323: 1337-1339
6. Rubba P, Mancini M (1995) Lipid-lowering treatment: effects on endothelial dysfunction. Curr Opin Lipidol 6: 348-353
7. Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 332: 512-521
8. Gould KL (1998) New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease. Am J Med 104: 2S-17S
9. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371-1375
10. Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefski EJ, Sheehan HM (1993) Intracoronary ultrasound imaging: correlation at plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol 21: 35-44
11. St.Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stadium ML, Popp RL (1991) Intravascular ultrasound imaging of angiographically normal coronary arteries: an in vivo comparison with quantitative angiography. J Am Coll Cardiol 18: 952-958
12. Mc Pherson DD, Hiratzka LF, Lamberth WC, Brandt B, Hunt M, Kieso RA, Marcus ML, Kerber RE (1987) Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. N Engl J Med 316: 304-309
13. White CW, Wright CB, Doty TB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML (1994) Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 310: 819-824
14. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG (1994) Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 330: 1772-1778
15. Folland ED, Vogel RA, Hartigan P, Bates ER, Beauman GJ, Fortin T, Boucher C, Parisi AF, and the Veteran Affairs ACME Investigators (1994) Relation between coronary artery stenosis assessed by visual, caliper and computer methods and exercise capacity in patients with single vessel coronary artery disease. Circulation 89: 2005-2014
16. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V (1988) Angiographic progression of coronary artery disease and the developement of myocardial infarction. J Am Coll Cardiol 12: 56-62
17. Little WC, Costantinescu M, Applegate RG (1988) Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78: 1157-1166
18. Mann J, Davies M (1996) Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 94: 928-931
19. Fishbein MC, Siegel RJ (1996) How big are coronary atherosclerotic plaques that rupture? Circulation 94: 2662-2666
20. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT Jr, Lakatta EG (1990) Prevalence and prognostic significance of exercise-induced silent myocardial ischaemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 81: 428-436
21. Krone RJ, Gregory RJ, Freedland KE, Kleiger RE, Wackers FJ, Bodenheimer MM, Benhorin J, Schwartz RJ, Parker JO, Van Voorhees L (1994) Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of coronary heart disease. J Am Coll Cardiol 24: 1274-1281
22. Harrison DG (1993) Endothelial dysfunction in coronary microcirculation: a clinical entity or an experimental finding? J Clin Invest 91: 1-2
23. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327: 534-536
24. Furchgott RF (1983) Role of endothelium in responses of vascular smooth muscle. Circ Res 53: 557-573
25. Adams DH, Show S (1994) Leukocyte-endothelial interactions and regulation of leukocytes migration. Lancet 343: 831-836
26. Introna M, Mantovani A (1997) Early activation signals in endothelial cells. Stimulation by cytokines. Arterioscler Thromb Vasc Biol 17: 423-428
27. Jang Y, Lincoff AM, Plow EF, Topol EJ (1994) Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24: 1591-1601
28. Lefer AM (1997) Nitric oxide: Nature's naturally occurring leukocyte inhibitor. Circulation 95: 553-554
29. Gauthier TW, Scalia R, Murohara T, Gou JP, Lefer AM (1995) Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 15: 1652-1659
30. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot FG, Sixma JJ (1992) Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85: 2284-2290
31. Azuma H, Ishikawa M, Sekizaki S (1986) Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88: 411-415
32. Ross R (1986) The pathogenesis of atherosclerosis. N Engl J Med 314: 448-500
33. Henderson AH (1991) Endothelium in control. Br Heart J 65: 116-125
34. Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615
35. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DM (1993) Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73: 164-171
36. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC (1996) Nitric oxide reversibly inhibits the migration of cultured smooth muscle cells. Circ Res 78: 225-230
37. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM (1994) Inhibition of vascular smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267: C1405-C1413
38. Vallance P, Collier J, Moncada S. (1989) Effects of endothelium-dependent nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-999
39. Gilligan DM, Panza JA, Kilcayne CM (1994) Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1990: 2853-2858
40. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H (1989) Coronary vasomotion in response to sympathetic stimulation: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14: 1181-1190
41. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046-1051
42. Gage J, Hess O, Murakami T, Raitter M, Grimm J, Krayenbuehl H. (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73: 865-876
43. Zeiher AM, Krause T, Schaechinger V, Minners J, Moser E (1995) Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischaemia. Circulation 91: 2345-2352
44. Yeung A, Vekshtein V, Krantz D, Vita JA, Ryan TJ Jr, Ganz P, Selwyn AP (1991) The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 325: 1551-1556
45. Deanfield JE, Shea M, Kensett M, Horlock P, Wilson, de Landsheere CM, Selwyn AP (1984) Silent myocardial ischaemia due to mental stress. Lancet 2: 1001-1005
46. Nabel E, Ganz P, Gordon J, Alexander R, Selwyn A (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77: 43-52
47. Meredith IT, Anderson TJ, Uehata A, Yeung AC, Selwyn AP, Ganz P (1993) Role of endothelium in ischemic coronary syndromes. Am J Cardiol 72: 27C-31C
48. Fuster V., Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242-250
49. Bache RJ (1998) Vasodilator reserve. A functional assessment of coronary health. Circulation 98: 1257-1260
50. Chilian WM, Eastham CL, Marcus ML (1986) Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol: 251: H779-H788
51. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A (1993) Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 328: 1659-1664
52. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24: 1474-1568
53. Blann AD, Taberner DA (1995) A reliable marker of endothelial cell dysfunction: Does it exist? Br J Haematol 90: 244-248
54. Mannucci PM (1998) von Willebrand factor. A marker of endothelial damage? Arterioscler Thromb Vasc Biol 18: 1359-1362
55. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M (1987) Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 327: 237-239
56. Wines PA, Schmitz JM, Pfister SL, Clubb FJ Jr, Buja LM, Willerson JT, Campbell WB (1989) Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbits. Arteriosclerosis 9: 195-202
57. Shimokawa H, Kim P, Vanhoutte PM (1988) Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic pigs. Circ Res 63: 604-612
58. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD (1988) Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 63: 903-910
59. Sellke FW, Armstrong ML, Harrison DG (1990) Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81: 1586-1593
60. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228-234
61. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115
62. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 340: 1340-1342
63. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE (1994) Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the Lipoprotein(a) level. J Clin Invest 93: 50-55
64. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Celermajer DS (1998) Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32: 123-127.
65. Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vascular tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391-401
66. Vita JA, Treasure CB, Nabel EJ, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors of coronary artery disease. Circulation 81: 491-497
67. Zeiher AM, Drexler, Saurbier B, Just H (1993) Effects of age, atherosclerosis, hypercholesterolemia and hypertension: endothelium-mediated coronary blood flow modulation in humans. J Clin Invest 92: 652-662
68. Egashira K, Inou T, Yamada A, Hirooka Y, Maruoka Y, Takeshita A (1993) Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and coronary atherosclerotic lesions. J Clin Invest 91: 29-37
69. Rubba P, Mercuri M, Faccenda F, Iannuzzi A, Irace C, Strisciuglio P, Gnasso A, Tang R, Andria G, Bond MG (1994) Premature carotid atherosclerosis: does it occur in both familial hypercholesterolemia and homocystinuria? Ultrasound assessment of arterial intima-media thickness and blood flow velocity. Stroke 25: 943-950
70. Gilligan DM, Guetta V, Panza J, Garcia CE, Quyumi AA, Cannon RO III (1994) Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 90: 35-41
71. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cook JP (1992) L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253
72. Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE (1998) Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 32: 110-116
73. Drexler H, Zeiher A, Meinzer K, Just H (1991) Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 338: 1546-1550
74. Galle J, Busse R, Bassenge E (1991) Hypercholesterolemia and atherosclerosis change vascular reactivity in rabbits by different mechanisms. Arterioscler Thromb 11: 1712-1718
75. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases superoxide anion production. J Clin Invest 91: 2546-2551
76. Pritchard KA, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemerman MB (1995) Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anions. Circ Res 77: 510-518
77. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA (1996) Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93: 2617-2622
78. Cosentino F, Katusic Z (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91: 139-144
79. Stroes E, Kastelein J, Cosentino F, Erkélens W, Wever R, Koomans H, Luscher T, Rabelink T (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99: 41-46
80. Schmitz G, Lackner K (1993) High density lipoproteins and atherosclerosis. Curr Opin Lipidol 4: 392-400
81. Harrison DG, Armstrong ML, Freiman PC, Heistad DD (1987) Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 80: 1808-1811
82. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese G, Mancini M (1990) Haemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 81: 610-616
83. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. (1997) Single LDL apheresis improves endothelium dependent vasodilation in hypercholesterolemic humans. Circulation 95: 76-82
84. Schmieder RE, Schobel HP (1995) Is endothelial dysfunction reversible? Am J Cardiol 76: 117A-121A
85. O'Driscoll GJ, Green DJ, Taylor RR (1997) Simvastatin, an HMGCoA reductase inhibitor, improves endothelial function within 1 month. Circulation 95: 1126-1131
86. John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE (1998) Increased bioavailability of nitric oxide after lipid lowering therapy in hypercholesterolemic patients. Circulation 98: 211-216
87. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA (1997) Vitamin C restores endothelium dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95: 2617-2622
88. Keaney JF Jr, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA (1993) Dietary anti-oxidants preserve endothelial-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 90: 11880-11884
89. Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F (1998) Additional benefit of Vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 32: 711-716
90. Clarkson P, Adams MR, Powe AJ, Donald AE, Mc Credie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE (1996) Oral L-arginine improves endothelium dependent dilation in hypercholesterolemic young adults. J Clin Invest 7: 1989-1994
91. Verhaar MC, Wever RMF, Kastelein JJP, van Dam T, Koomans HA, Rabelink TJ. (1998) 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97: 237-241
92. Leung WH, Lan CP, Wong CK (1994) Beneficial effects of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 344: 1383-1389
93. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW (1995) Beneficial effect of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332: 481-487
94. Anderson TJ, Meredith IT, Yeuhg AG, Frei B, Selwyn AP, Ganz P (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332: 488-493
95. Egashira K, Hirroka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A (1994) Reduction in serum cholesterol with Pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89: 2519-2524
96. Seiler C, Suter TM, Hess OM (1995) Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate. J Am Coll Cardiol 26: 1615-1622
97. Lance Gould K, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ (1994) Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by Positron Emission Tomography after Dipyridamole in patients with coronary artery disease. Circulation 89: 1530-1538
98. Eichstaedt HW, Eskoetter H, Hoffmann I, Amthauer HW, Weidinger G (1995) Improvement of myocardial perfusion by short-term Fluvastatin therapy in coronary artery disease. Am J Cardiol 76: 122A-125A
99. de Divitiis M, Rubba P, Di Somma S, Liguori V, Galderisi M, Montefusco S, Carreras G, Greco V, Carotenuto A, Iannuzzo G, de Divitiis O (1996) Effect of short-term reduction in serum cholesterol with Simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia. Am J Cardiol 78: 763-768
100. Huggins GS, Pasternak RC, Alpert MA, Fischman AJ, Gewirtz H (1998) Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve. Circulation 98: 1291-1296
101. van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJGM, Lie KL, Bruschke AVG, REGRESS Study Group (1996) Reduction of transient myocardial ischemia with Pravastatin in addition to the conventional treatment in patients with angina pectoris. Circulation 94: 1503-1505
102. Andrews TC, Raby K, Barry J, Naimi CL, Alfred E, Ganz OP, Selwyn AP (1997) Effect of cholesterol reduction on myocardial ischaemia in patients with coronary disease. Circulation 95: 324-382
103. Deanfield JE, Shea M, Ribeiro P, de Landsheere CM, Wilson RA, Horlock P, Selwyn AP (1984) Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 54: 1195-1200
104. Benhorin J, Banai S, Moriel M, Gavish A, Stern S, Tzivoni D (1993) Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes. Circulation 87: 808-814